YZY Biopharma Co.
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $31M
Investors
- 7
About YZY Biopharma Co.
, Ltd is a biotechnology medicine developer that focuses on the development of bispecific antibody drugs. Pengfei Zhou, the founder and president of the company, worked at Schering-Plough, Sino-American Crown Bio, Pfizer-Crown Asia Cancer Research Center, etc. The company has a 4,000 square meter R&D building and an 800 square meter antibody pilot production workshop and applied for 83 core technology patents, including 14 PCT international patents, and received 32 invention patent authorizations. In September 2023, it was listed on the Hong Kong Stock Exchange. The company engages in the development of bispecific antibody drugs. Its main products include bispecific antibody products such as M802—HER2×CD3, M701—EPCAM×CD3 and Y150. The company's products are used in diseases such as tumors, immunity, inflammation, cardiovascular and infections.86 million.
Who invested in YZY Biopharma Co.
7 investors across 3 rounds
See all investors in YZY Biopharma Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about YZY Biopharma Co.
Who invested in YZY Biopharma Co.?
YZY Biopharma Co. has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has YZY Biopharma Co. raised?
YZY Biopharma Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did YZY Biopharma Co. last raise money?
YZY Biopharma Co.'s most recent round on record is a Series B, in Sep 2021.
What does YZY Biopharma Co. do?
, Ltd is a biotechnology medicine developer that focuses on the development of bispecific antibody drugs.
Where is YZY Biopharma Co. headquartered?
YZY Biopharma Co. is headquartered in Wuhan, China.
Which VCs invest in companies like YZY Biopharma Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at YZY Biopharma Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like YZY Biopharma Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.